Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial-Reference-Cited by-同舟云学术

Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial

Published:2017-03 Issue:3 Volume:18 Page:404-412
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Dréno Brigitte,Kunstfeld Rainer,Hauschild Axel,Fosko Scott,Zloty David,Labeille Bruno,Grob Jean-Jacques,Puig Susana,Gilberg Frank,Bergström Daniel,Page Damian R,Rogers Gary,Schadendorf Dirk

Publisher

Elsevier BV

Subject

Oncology

Reference13 articles.

1. Basal-cell carcinoma;Rubin;N Engl J Med,2005

2. Basal cell carcinomas: attack of the hedgehog;Epstein;Nat Rev Cancer,2008

3. Advanced basal cell carcinoma: epidemiology and therapeutic innovations;Mohan;Curr Dermatol Rep,2014

4. Basal cell nevus syndrome;BCNS,2012

5. Clinical experience with Hedgehog pathway inhibitors;Low;J Clin Oncol,2010

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S2k-Leitlinie Basalzellkarzinom der Haut;Forum;2024-07-17

2. Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances;Current Oncology Reports;2024-07-02

3. Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non−Small Cell Lung Cancer;JAMA Oncology;2024-07-01

4. Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies;American Journal of Clinical Dermatology;2024-06-19

5. Enhancing Therapeutic Efficacy in Cancer Treatment: Integrating Nanomedicine with Autophagy Inhibition Strategies;ACS Omega;2024-06-18